BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 35276059)

  • 1. Identification and verification of the ferroptosis- and pyroptosis-associated prognostic signature for low-grade glioma.
    Wang J; Ren J; Liu J; Zhang L; Yuan Q; Dong B
    Bosn J Basic Med Sci; 2022 Sep; 22(5):728-750. PubMed ID: 35276059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic transcriptome profiling of pyroptosis related signature for predicting prognosis and immune landscape in lower grade glioma.
    Yu H; Gong M; Qi J; Zhao C; Niu W; Sun S; Li S; Hong B; Qian J; Wang H; Chen X; Fang Z
    BMC Cancer; 2022 Aug; 22(1):885. PubMed ID: 35964070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machine learning identification of cuproptosis and necroptosis-associated molecular subtypes to aid in prognosis assessment and immunotherapy response prediction in low-grade glioma.
    Miao Y; Liu J; Liu X; Yuan Q; Li H; Zhang Y; Zhan Y; Feng X
    Front Genet; 2022; 13():951239. PubMed ID: 36186436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyroptosis: a novel signature to predict prognosis and immunotherapy response in gliomas.
    He G; Chen Z; Zhuo S; Tang J; Hao W; Yang K; Yang C
    Hum Cell; 2022 Nov; 35(6):1976-1992. PubMed ID: 36129672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An autophagic gene-based signature to predict the survival of patients with low-grade gliomas.
    Chen J; Li Y; Han X; Pan Y; Qian X
    Cancer Med; 2021 Mar; 10(5):1848-1859. PubMed ID: 33591634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy.
    Teng C; Zhu Y; Li Y; Dai L; Pan Z; Wanggou S; Li X
    Front Immunol; 2022; 13():899710. PubMed ID: 35677036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-Related lncRNA Correlates With Prognosis and Immune Microenvironment in Lower-Grade Glioma.
    Xu S; Tang L; Liu Z; Luo C; Cheng Q
    Front Immunol; 2021; 12():731048. PubMed ID: 34659218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a novel cuproptosis-related gene signature and integrative analyses in patients with lower-grade gliomas.
    Bao JH; Lu WC; Duan H; Ye YQ; Li JB; Liao WT; Li YC; Sun YP
    Front Immunol; 2022; 13():933973. PubMed ID: 36045691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel pyroptosis-related gene signature predicts the prognosis of glioma through immune infiltration.
    Zhang M; Cheng Y; Xue Z; Sun Q; Zhang J
    BMC Cancer; 2021 Dec; 21(1):1311. PubMed ID: 34876094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Model and Nomogram Construction Based on a Novel Ferroptosis-Related Gene Signature in Lower-Grade Glioma.
    Zhao J; Liu Z; Zheng X; Gao H; Li L
    Front Genet; 2021; 12():753680. PubMed ID: 34819946
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationships of Ferroptosis and Pyroptosis-Related Genes with Clinical Prognosis and Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma.
    Yu J; Chen Y; Pan X; Wen W
    Oxid Med Cell Longev; 2022; 2022():3713929. PubMed ID: 36246400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of cancer immunotherapy through pyroptosis: A pyroptosis-related signature predicts survival benefit and potential synergy for immunotherapy in glioma.
    Zeng Y; Cai Y; Chai P; Mao Y; Chen Y; Wang L; Zeng K; Zhan Z; Xie Y; Li C; Zhan H; Zhao L; Chen X; Zhu X; Liu Y; Chen M; Song Y; Zhou A
    Front Immunol; 2022; 13():961933. PubMed ID: 35990696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and Validation of a Ferroptosis-Related lncRNA Signature for Prognosis Prediction in Lower-Grade Glioma.
    Huang QR; Li JW; Yan P; Jiang Q; Guo FZ; Zhao YN; Mo LG
    Front Neurol; 2022; 13():861438. PubMed ID: 35832170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferroptosis-related gene signature predicts prognosis and immunotherapy in glioma.
    Wan RJ; Peng W; Xia QX; Zhou HH; Mao XY
    CNS Neurosci Ther; 2021 Aug; 27(8):973-986. PubMed ID: 33969928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of DNA Damage Repair Related Signature and Molecular Feature in Low-Grade Gliomas to Aid Chemotherapy and Drug Discovery.
    Yin X; Li M; He Z
    Front Biosci (Landmark Ed); 2023 Oct; 28(10):234. PubMed ID: 37919061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ferroptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of glioma patients.
    Hu Y; Tu Z; Lei K; Huang K; Zhu X
    Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34726238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Risk Signature with Seven Pyroptosis-Related Genes for Prognosis Prediction in Glioma.
    Huang Q; Li J; Mo L; Zhao Y
    World Neurosurg; 2022 Mar; 159():e285-e302. PubMed ID: 34929369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive regulators of T cell functions as predictors of prognosis and microenvironment characteristics of low-grade gliomas.
    Li Y; Feng Y; Luo F; Peng G; Li Y
    Front Immunol; 2022; 13():1089792. PubMed ID: 36726969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferroptosis in Low-Grade Glioma: A New Marker for Diagnosis and Prognosis.
    Liu Y; Xu Z; Jin T; Xu K; Liu M; Xu H
    Med Sci Monit; 2020 Jun; 26():e921947. PubMed ID: 32484805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.
    Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M
    Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.